---  
layout: startup_page  
title: "Asgard Therapeutics"  
id: "asgardthx.com"  
permalink: "/asgardtherapeuticsasgardthx.com03142024/"  
website: "https://www.asgardthx.com/"  
funding_round: "Series A"  
funding_amount: "€30M"  
investors: "RV Invest, Johnson & Johnson Innovation – JJDC, Inc., Novo Holdings, Boehringer Ingelheim Venture Fund, Industrifonden"  
about: "Asgard Therapeutics is a biotech company developing in vivo direct cell reprogramming for cancer immunotherapy. Their lead program, AT-108, reprograms tumor cells into antigen-presenting dendritic cells, triggering a personalized anti-tumor immune response. This approach offers a potential breakthrough in cancer treatment by overcoming challenges faced by traditional cell therapies."  
markets: "Biotechnology, Immunotherapy, Oncology, Gene Therapy"  
hq: "Lund, Skåne, Sweden"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/asgardthx/"  
twitter: "https://twitter.com/AsgardThx"  
instagram: ""  
facebook: "https://www.facebook.com/asgardthx"  
crunchbase: "https://www.crunchbase.com/organization/asgard-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/265877-38"  

date_display: "14-Mar-2024"  
date: "2024-03-14"

# SEO Optimization  
meta_title: "Asgard Therapeutics - Series A Funding (€30M)"  
meta_description: "Asgard Therapeutics, Asgard Therapeutics is a biotech company developing in vivo direct cell reprogramming for cancer immunotherapy. Their lead program, AT-108, reprograms..."  
meta_keywords: "Asgard Therapeutics, Biotechnology, Immunotherapy, Oncology, Gene Therapy, Series A funding"  
canonical_url: "https://startup.projectstartups.com/asgardtherapeuticsasgardthx.com03142024/"  
---